The 29th Annual BioNJ Dinner, held at the Hilton East Brunswick last week, was the organization’s first live dinner since February 2020. The life sciences community in New Jersey fully supported an inspiring evening, celebrating unprecedented medical innovation from the Garden State. .
BioNJ CEO and President Debbie Hart told an audience of life science professionals: You are the reason we are here tonight.
“It’s safe to say the past two years have been tumultuous. Despite the turmoil, the past two years have seen 70 new FDA drug approvals from companies located in New Jersey. all NEW APPROVALS – Our great state has continued to lead the way in helping patients live longer and better lives. ”
During the dinner program, the 2022 Annual Dr. Sol J. Barer Award for Vision, Innovation, and Leadership was presented to New Jersey Commissioner of Health Judith Persichilli.
“When the COVID-19 pandemic hit New Jersey, Judy used her decades of experience in nursing, hospital management, and public health to implement never-before-seen systems in hospitals, helping doctors and Protecting nurses and ensuring patients get the care they need, said Barer, board member of BioNJ, former chairman and CEO of Celgene Corp., and president of Teva Pharmaceutical Industries. He said:
Citing her steadfast leadership during an unprecedented time, Hart said:
Having discussed the importance of leadership, partnership and innovation in the COVID-19 pandemic, Persichilli happily accepted the award.
Persichilli, who oversees the state’s health care system and whose primary mission is to help New Jerseyers live healthier, longer lives, said mission-oriented leadership grounded in a strong foundation of values ”will serve all of us.” It’s an engine that inspires…that’s what I experienced repeatedly during the pandemic.”
The evening kicked off with the announcement of the Innovator Awards for 43 innovator companies that have achieved 70 FDA drug approvals in 2020 and 2021.
- Durysta, Oriahnn, Quilipta, Vuity’s AbbVie
- Jinronta’s ADC treatment
- Twirla Agile Therapies
- Altera Pharmaceuticals for Roszet
- Ascendis Pharma for Skytropha
- Athenex of Chrysiri
- Bayer of Kerendia and Lampit
- Boehringer Ingelheim for Trijardy XR
- Bristol-Myers Squibb of Abecma, Breyanzi, Onureg and Zeposia
- Tarpeyo’s Calliditas Therapeutics
- Dr. Reddy’s for Elyxyb and Xeglyze
- Dartisla ODT Edenbridge Pharmaceuticals
- Lyumjev, Retevmo, Tauvid, Eli Lilly and Co. of Trijardy XR.
- Endo International for Qwo
- Tivdak’s Genmab
- Gilead Sciences for Trodelvy and Veklury
- Blenrep and Jemperli’s GSK
- Helsinn in Truseltiq
- Hikma Pharmaceuticals for Kloxxado
- Ponvory and Rybrevant by Janssen Pharmaceutical Cos. of Johnson & Johnson
- Adbury’s LEO Pharma
- Melinta Therapeutics for Chimilsa
- Merck & Co. of Vaxneuvance, Verquvo and Welireg.
- Kesimpta, Leqvio, Semblix, Novartis Tabrecta
- Novo Nordisk for Sogroya and Wegovy
- Biltepso’s NS Pharma
- Otsuka Pharmaceutical Incobi
- Oyster Point Pharma for Tilbaya
- Comirnaty, Prevnar 20, TicoVac Pfizer
- Pharmacosmos of Monoferic
- Record Rare Diseases of Cystadrops and Isturisa
- Regeneron Pharmaceuticals for Evkeeza and Inmazeb
- RVL Pharmaceuticals for Upnik
- Fexinidazole, MenQuadfi, Nexviazyme, Sarclisa Sanofi
- Synexis for brexafem
- Seqirus of Odenz
- Sunovion Pharmaceuticals for Kinmobi
- Sun Pharmaceutical Industries for Winlevi
- Taiho Oncology for Incovi
- Ukonik TG Therapeutics
- Jelmyto’s UroGen Pharma
- ViiV Healthcare from Apretude, Cabenuva and Rukobia
- Danyelza’s Y-mAb therapeutic
The 4th Annual Heart of BioNJ Awards were presented to COVID-19 Heroes in New Jersey. A member of BioNJ, he has impacted the state and the world in the fight against the pandemic through innovation, partnerships and dedication. Winners are:
- Dr. Andrew Brooks (Postmortem): Leading the discovery of the first COVID-19 saliva-based test
- Dr. Brian Strom: BioNJ’s trusted expert and epidemiologist, educating communities and leading the fight against COVID-19 at Rutgers University and beyond
- Minister Mary Phillips-Blackshear: Pfizer COVID-19 Vaccine Clinical Trial Participants
- Amy Mansue: Leading healthcare workers across the Inspira Health Network in their tireless efforts to care for patients with COVID-19
- Jean Walters: Johnson & Johnson’s Janssen COVID-19 Vaccine Clinical Trial Participants
- Eli Lilly: Bamlanivimab & Etesevimab
- Fosun Pharma: COVID-19 RT-PCR Detection Kit
- Gilead Science: Veklury
- GSK: Sotrovimab
- Johnson & Johnson/Janssen: JNJ-78436735 COVID-19 vaccine
- Merck & Co.: Manufacture of Mornupiravir and COVID-19 Vaccine
- Novartis: manufacturing the COVID-19 vaccine
- Pfizer: Comirnaty COVID-19 Vaccine and Paxlovid
- Princeton University: Ventilator Milano
- Rutgers, New Jersey State University: First saliva-based COVID-19 test
- Sanofi: manufacturing the COVID-19 vaccine